Nexstim
Pre-clinicalNexstim nTMS uses the latest advances in 3D imaging to precisely target the E-field and reliably quantify the dose received by the patient.
Founded
2000
Focus
NeuroscienceMedical Devices
About
Nexstim nTMS uses the latest advances in 3D imaging to precisely target the E-field and reliably quantify the dose received by the patient.
Funding History
2Total raised: $20M
IPO$8MUndisclosedJun 15, 2015
Series B$12MFinnish Industry InvestmentApr 15, 2013
Company Info
TypePrivate
Founded2000
LocationHelsinki, Finland
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
3PBIOVIAN
Pre-clinical · Turku
Faron Pharmaceuticals
Phase 1/2 · Turku
Finvector Vision Therapies
Pre-clinical · Kuopio
Bone Index
Pre-clinical · Kuopio
Genomill Health
Pre-clinical · Helsinki
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile